|
Post by kdaddyfresh2000 on Nov 9, 2015 18:25:51 GMT -5
Please do not lock this thread which is created b/c the following thread was locked. 3Q15 ER Mon 11/9/15; BoD to convene Nov 2nd half to decide created Oct 29, 2015 at 1:43pm mnkd.proboards.com/thread/3875/3q15-mon-convene-half-decide?page=5Hakan 3Q15 CC 11/9/15: Negotiating with many for TS partnership- Will have partner by end of year The 50M Mnkd Shares TASE index funds got is such a sweet deal. Al'd rather offer to them than Sny. He really plays hard ball w/ Sny who must be really stingy. Hakan never said Will partner by end of year. Yep. He never said partner. More of the same "we are in energetic negotiations at this time" rhetoric with no concrete positive results from yet another CC. Lots of concrete negative results, however.
|
|
|
Post by kdaddyfresh2000 on Nov 9, 2015 18:26:38 GMT -5
Hakan opened his part begging for a partner - they will have a field day with that one. I found that so odd, almost asking for a white knight to save them from Sanofi was how i read that. That was a real eye-opener for me as well.
|
|
|
Post by kball on Nov 9, 2015 18:27:21 GMT -5
Fortunately pic cuts off before manboobs
|
|
|
Post by mindovermatter on Nov 9, 2015 18:27:37 GMT -5
I mentioned in my first post here that I know someone who is familiar with the pharma world and doing deals. I listened to the call and Hakan, to my recollection, did not say a new TS deal was in the works. What he said is that they are in negotiations. Negotiations in pharma speak doesn't mean a deal is imminent. On the contrary, pharmaceutical companies are always in "negotiations" with numerous companies. They will look at hundreds if not thousands of deals a year and if lucky, might do one. All of those are "negotiations." So I would tell everyone to temper their expectations about a new technosphere deal because we have heard Hakan and, I think, Matt discuss this over the last 2 calls and yet we have heard nothing new. Why? Because those "negotiations" are just informal talk but not serious discussions about forming a partnership. It could also be that the company had a pending deal and the other side backed out. That happens often especially if the other company gets the sense that Mannkind is in desperate straits, which from today's call sounds like they are. Any company that senses this will use that to get a better deal for them. What ever the issues are, today's conference call was not a confidence booster and showed that Mannkind has some serious problems. And you can bet that the analysts are going to reiterate their sell recs and even point out that Mannkind might not make it through 2016 if Afrezza doesn't start to sell. I would not be surprised to see MNKD hit the lows we saw back in 2012. I know some of you are very loyal to Al and the company and you'll see what you want to see but any student of business knows that Mannkind has put itself in a very precarious situation at this point in time. We all better hope that Hakan's hope of better Afrezza sales happens sooner rather than later.
|
|
|
Post by miracle331 on Nov 9, 2015 18:28:11 GMT -5
I think we all lost our shirts lol
|
|
|
Post by silentknight on Nov 9, 2015 18:29:48 GMT -5
No specific candidates come to mind, but the prime candidate would likely be someone with past experience in the senior management team of a BP who is looking to get back into the game with something to prove. Someone who knows BP culture, marketing, and regulatory process with a proven record of success. Perhaps a senior VP or retired CEO. It would take an incredible incentive package, but I don't think anyone would take the job knowing that SNY was pulling all the strings with Afrezza.
|
|
|
Post by mindovermatter on Nov 9, 2015 18:32:41 GMT -5
Hakan opened his part begging for a partner - they will have a field day with that one. Wild speculation on my part but maybe it was Hakan's clever way to send a message to Sanofi that Mannkind has another willing partner if Sanofi doesn't pick things up.
|
|
|
Post by bradleysbest on Nov 9, 2015 18:34:14 GMT -5
That's why I believe DTC is crucial now! It will create demand, awareness (patients & doctors) as well as an increase in script numbers. Time is not on our side & we need things to start sooner rather later. Insurance coverage can be altered as the demand begins increasing.
|
|
|
Post by purge on Nov 9, 2015 18:42:54 GMT -5
Purge: Frothing at the mouth doesn't look good on you. I was happy to hear that a TS deal is in the works. I will believe there is a deal when I see a PR for a signed deal. Until then there is no deal. You are more trusting than I am....I have been here since way before Al Mann's famous, "Minimal Dilution," comments.
The best predictor of the future is the past. Take this management's word with a grain of salt.
|
|
|
Post by jefferson on Nov 9, 2015 18:45:28 GMT -5
Who are these people?
|
|
|
Post by stevil on Nov 9, 2015 19:03:40 GMT -5
Hakan opened his part begging for a partner - they will have a field day with that one. Wild speculation on my part but maybe it was Hakan's clever way to send a message to Sanofi that Mannkind has another willing partner if Sanofi doesn't pick things up. No, just no. MNKD has the cards, but SNY owns all the chips. Don't be fooled in who has the power right now. SNY doesn't need MNKD. MNKD needs SNY until someone else comes along. SNY wouldn't lose a second of sleep over losing MNKD. But they will lose millions more by keeping them.
|
|
|
Post by mindovermatter on Nov 9, 2015 19:12:20 GMT -5
Wild speculation on my part but maybe it was Hakan's clever way to send a message to Sanofi that Mannkind has another willing partner if Sanofi doesn't pick things up. No, just no. MNKD has the cards, but SNY owns all the chips. Don't be fooled in who has the power right now. SNY doesn't need MNKD. MNKD needs SNY until someone else comes along. SNY wouldn't lose a second of sleep over losing MNKD. But they will lose millions more by keeping them. As I mentioned, Plan B might be starting to take effect if the partnership is at the beginning of the end.
|
|
|
Post by lakers on Nov 9, 2015 19:27:18 GMT -5
I mentioned in my first post here that I know someone who is familiar with the pharma world and doing deals. I listened to the call and Hakan, to my recollection, did not say a new TS deal was in the works. What he said is that they are in negotiations. Negotiations in pharma speak doesn't mean a deal is imminent. On the contrary, pharmaceutical companies are always in "negotiations" with numerous companies. They will look at hundreds if not thousands of deals a year and if lucky, might do one. All of those are "negotiations." So I would tell everyone to temper their expectations about a new technosphere deal because we have heard Hakan and, I think, Matt discuss this over the last 2 calls and yet we have heard nothing new. Why? Because those "negotiations" are just informal talk but not serious discussions about forming a partnership. It could also be that the company had a pending deal and the other side backed out. That happens often especially if the other company gets the sense that Mannkind is in desperate straits, which from today's call sounds like they are. Any company that senses this will use that to get a better deal for them. What ever the issues are, today's conference call was not a confidence booster and showed that Mannkind has some serious problems. And you can bet that the analysts are going to reiterate their sell recs and even point out that Mannkind might not make it through 2016 if Afrezza doesn't start to sell. I would not be surprised to see MNKD hit the lows we saw back in 2012. I know some of you are very loyal to Al and the company and you'll see what you want to see but any student of business knows that Mannkind has put itself in a very precarious situation at this point in time. We all better hope that Hakan's hope of better Afrezza sales happens sooner rather than later. -She believes that Afrezza will ultimately have more success outside the United States because of how medicine is dispensed in socialized health. But that will impact how successful Afrezza is revenue wise. If Sanofi believes Afrezza can become a monopoly in the fast acting parandial insulin market by displacing needle based insulin, better to be a monopoly with lower margins than having nothing at all. She believes that Health ministries could make Afrezza the insulin of choice assuming they see the benefits of Afrezza with increased compliance that lowers over all cost of care for diabetics. If the data supports what we are initially seeing, Sanofi has the ability politically to get health ministries to make the move to Afrezza as the first line of care. In regards to the US, she isn't so sure Afrezza will become a leader due to how drugs are marketed and sold here. She said it will ultimately come down to whether or not Doctors become comfortable prescribing an insulin that is absorbed in the lungs after decades of being comfortable with needle based delivery. Read more: mnkd.proboards.com/user/1958/recent#ixzz3r2k5RVL7I agree w/ what you and your lady friend said. That's why 1Q16 will be the watershed moment for international expansion. The PBM in US is so fragmented. Afrezza will have an easier time in a National Health Care system in my previous threads. 10-Q: U.S. 3rd Party Payor vs EU Pricing System Read more: mnkd.proboards.com/thread/3768/3rd-party-payor-pricing-system#ixzz3r2mG9pnPInternational Pharmaceutical Law and Practice mnkd.proboards.com/thread/3844/drug-approval-process-countries
|
|
|
Post by stevil on Nov 9, 2015 19:51:57 GMT -5
Lakers,
Did you ever come out with the big news you said was coming soon?
|
|
|
Post by nylefty on Nov 9, 2015 19:58:29 GMT -5
Please do not lock this thread which is created b/c the following thread was locked. 3Q15 ER Mon 11/9/15; BoD to convene Nov 2nd half to decide created Oct 29, 2015 at 1:43pm mnkd.proboards.com/thread/3875/3q15-mon-convene-half-decide?page=5Hakan 3Q15 CC 11/9/15: Negotiating with many for TS partnership- Will have partner by end of year The 50M Mnkd Shares TASE index funds got is such a sweet deal. Al'd rather offer to them than Sny. He really plays hard ball w/ Sny who must be really stingy. Hakan never said Will partner by end of year. He said by the end of the year or in the next quarter.
|
|